Allergy Immunotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065086
  • May 2021
  • Pharmaceuticals
  • 131 Pages
The global Allergy Immunotherapy market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Allergy Immunotherapy market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Allergy Immunotherapy market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Allergy Immunotherapy market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Merck KGaA, DBV Technologies, ALK, Allergy Therapeutics, HAL Allergy B.V., Aimmune Therapeutics, Circassia, Anergis, Biomay AG, Stallergenes Greer
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Allergy Immunotherapy market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Allergy Immunotherapy market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Allergy Immunotherapy market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Allergy Immunotherapy market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Allergy Immunotherapy Market:
The Allergy Immunotherapy market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Merck KGaA, DBV Technologies, ALK, Allergy Therapeutics, HAL Allergy B.V., Aimmune Therapeutics, Circassia, Anergis, Biomay AG, Stallergenes Greer

Allergy Immunotherapy Market Segment Analysis:
by Treatment
Subcutaneous Immunotherapy
SCIT
Sublingual Immunotherapy
SLIT
Allergy Type
Asthma
Food Allergy
Allergic Rhinitis
Venom Allergy
Others
Distribution Channel
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Online Pharmacies

Geographic Coverage for Allergy Immunotherapy Market:
The market research report on global Allergy Immunotherapy market offers complete analysis across various regions across the world. The Allergy Immunotherapy market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Allergy Immunotherapy market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Allergy Immunotherapy Market Value and Forecast
  • US
  • Canada
Europe Allergy Immunotherapy Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Allergy Immunotherapy Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Allergy Immunotherapy Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Allergy Immunotherapy Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Allergy Immunotherapy market report:
  • The report provides key trends of the global Allergy Immunotherapy market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Allergy Immunotherapy industry
  • The report covers all the recent developments of the Allergy Immunotherapy market and helps to provide current industry updates
  • The report covers a detailed look over the global Allergy Immunotherapy Industry and provides with significant actionable insights
  • The Allergy Immunotherapy market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Allergy Immunotherapy market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Allergy Immunotherapy market
  • Comprehensive analysis of the Allergy Immunotherapy market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Allergy Immunotherapy market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Allergy Immunotherapy market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Allergy Immunotherapy market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Allergy Immunotherapy market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Allergy Immunotherapy market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Merck KGaA
  • DBV Technologies
  • ALK
  • Allergy Therapeutics
  • HAL Allergy B.V.
  • Aimmune Therapeutics
  • Circassia
  • Anergis
  • Biomay AG
  • Stallergenes Greer
  • Subcutaneous Immunotherapy
  • SCIT
  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Allergy Immunotherapy Market Snapshot
          2.1.1. Global Allergy Immunotherapy Market By Treatment,2019
               2.1.1.1.Subcutaneous Immunotherapy
               2.1.1.2.SCIT
          2.1.2. Global Allergy Immunotherapy Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies & Drug Stores
               2.1.2.3.Online Pharmacies
          2.1.3. Global Allergy Immunotherapy Market By End-use,2019
          2.1.4. Global Allergy Immunotherapy Market By Geography,2019

3. Global Allergy Immunotherapy Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Allergy Immunotherapy Market Size (US$), By Treatment, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Treatment, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Treatment, 2020
     4.2. Global Allergy Immunotherapy Market Size (US$), By Treatment, 2018 – 2028

5. Global Allergy Immunotherapy Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Allergy Immunotherapy Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Allergy Immunotherapy Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Allergy Immunotherapy Market Size (US$), By End-use, 2018 – 2028

7. Global Allergy Immunotherapy Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Allergy Immunotherapy Market Analysis, 2018 – 2028 
          7.2.1. North America Allergy Immunotherapy Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Allergy Immunotherapy Market Size (US$), By Treatment, 2018 – 2028
          7.2.3. North America Allergy Immunotherapy Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Allergy Immunotherapy Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Allergy Immunotherapy Market Analysis, 2018 – 2028 
          7.3.1.  Europe Allergy Immunotherapy Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Allergy Immunotherapy Market Size (US$), By Treatment, 2018 – 2028
          7.3.3. Europe Allergy Immunotherapy Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Allergy Immunotherapy Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Allergy Immunotherapy Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Allergy Immunotherapy Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Allergy Immunotherapy Market Size (US$), By Treatment, 2018 – 2028
          7.4.3. Asia Pacific Allergy Immunotherapy Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Allergy Immunotherapy Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Allergy Immunotherapy Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Allergy Immunotherapy Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Allergy Immunotherapy Market Size (US$), By Treatment, 2018 – 2028
          7.5.3. Latin America Allergy Immunotherapy Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Allergy Immunotherapy Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Allergy Immunotherapy Market Analysis, 2018 – 2028 
          7.6.1.  MEA Allergy Immunotherapy Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Allergy Immunotherapy Market Size (US$), By Treatment, 2018 – 2028
          7.6.3. MEA Allergy Immunotherapy Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Allergy Immunotherapy Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Allergy Immunotherapy Providers
        8.4.1 Merck KGaA
                8.4.1.1 Business Description
                8.4.1.2 Merck KGaA Geographic Operations
                8.4.1.3 Merck KGaA Financial Information
                8.4.1.4 Merck KGaA Product Positions/Portfolio
                8.4.1.5 Merck KGaA Key Developments
        8.4.2 DBV Technologies
                8.4.2.1 Business Description
                8.4.2.2 DBV Technologies Geographic Operations
                8.4.2.3 DBV Technologies Financial Information
                8.4.2.4 DBV Technologies Product Positions/Portfolio
                8.4.2.5 DBV Technologies Key Developments
        8.4.3 ALK
                8.4.3.1 Business Description
                8.4.3.2 ALK Geographic Operations
                8.4.3.3 ALK Financial Information
                8.4.3.4 ALK Product Positions/Portfolio
                8.4.3.5 ALK Key Developments
        8.4.4 Allergy Therapeutics
                8.4.4.1 Business Description
                8.4.4.2 Allergy Therapeutics Geographic Operations
                8.4.4.3 Allergy Therapeutics Financial Information
                8.4.4.4 Allergy Therapeutics Product Positions/Portfolio
                8.4.4.5 Allergy Therapeutics Key Developments
        8.4.5 HAL Allergy B.V.
                8.4.5.1 Business Description
                8.4.5.2 HAL Allergy B.V. Geographic Operations
                8.4.5.3 HAL Allergy B.V. Financial Information
                8.4.5.4 HAL Allergy B.V. Product Positions/Portfolio
                8.4.5.5 HAL Allergy B.V. Key Developments
        8.4.6 Aimmune Therapeutics
                8.4.6.1 Business Description
                8.4.6.2 Aimmune Therapeutics Geographic Operations
                8.4.6.3 Aimmune Therapeutics Financial Information
                8.4.6.4 Aimmune Therapeutics Product Positions/Portfolio
                8.4.6.5 Aimmune Therapeutics Key Developments
        8.4.7 Circassia
                8.4.7.1 Business Description
                8.4.7.2 Circassia Geographic Operations
                8.4.7.3 Circassia Financial Information
                8.4.7.4 Circassia Product Positions/Portfolio
                8.4.7.5 Circassia Key Developments
        8.4.8 Anergis
                8.4.8.1 Business Description
                8.4.8.2 Anergis Geographic Operations
                8.4.8.3 Anergis Financial Information
                8.4.8.4 Anergis Product Positions/Portfolio
                8.4.8.5 Anergis Key Developments
        8.4.9 Biomay AG
                8.4.9.1 Business Description
                8.4.9.2 Biomay AG Geographic Operations
                8.4.9.3 Biomay AG Financial Information
                8.4.9.4 Biomay AG Product Positions/Portfolio
                8.4.9.5 Biomay AG Key Developments
        8.4.10 Stallergenes Greer
                8.4.10.1 Business Description
                8.4.10.2 Stallergenes Greer Geographic Operations
                8.4.10.3 Stallergenes Greer Financial Information
                8.4.10.4 Stallergenes Greer Product Positions/Portfolio
                8.4.10.5 Stallergenes Greer Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Allergy Immunotherapy Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Allergy Immunotherapy Market Revenue, By Treatment, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Allergy Immunotherapy Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Allergy Immunotherapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Allergy Immunotherapy Market Revenue, By Treatment, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Allergy Immunotherapy Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Allergy Immunotherapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Allergy Immunotherapy Market Revenue, By Treatment, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Allergy Immunotherapy Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Allergy Immunotherapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Allergy Immunotherapy Market Revenue, By Treatment, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Allergy Immunotherapy Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Allergy Immunotherapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Allergy Immunotherapy Market Revenue, By Treatment, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Allergy Immunotherapy Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Allergy Immunotherapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Allergy Immunotherapy: Market Segmentation 
FIG. 2 Global Allergy Immunotherapy Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Allergy Immunotherapy Market, By Treatment, 2019 (US$ Mn) 
FIG. 5 Global Allergy Immunotherapy Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Allergy Immunotherapy Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Allergy Immunotherapy Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Allergy Immunotherapy Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Allergy Immunotherapy Providers, 2019
FIG. 11 Global Allergy Immunotherapy Market Revenue Contribution, By Treatment, 2019 & 2028 (Value %) 
FIG. 12 Global Allergy Immunotherapy Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Allergy Immunotherapy Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Allergy Immunotherapy Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Allergy Immunotherapy Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Allergy Immunotherapy Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Allergy Immunotherapy Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Allergy Immunotherapy Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Allergy Immunotherapy market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Allergy Immunotherapy Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Allergy Immunotherapy Market Value, By Segment1, 2018 – 2028
TABLE  North America Allergy Immunotherapy Market Value, By Segment2, 2018 – 2028
TABLE  North America Allergy Immunotherapy Market Value, By Country, 2018 – 2028
TABLE  Europe Allergy Immunotherapy Market Value, By Segment1, 2018 – 2028
TABLE  Europe Allergy Immunotherapy Market Value, By Segment2, 2018 – 2028
TABLE  Europe Allergy Immunotherapy Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Allergy Immunotherapy Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Allergy Immunotherapy Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Allergy Immunotherapy Market Value, By Country, 2018 – 2028
TABLE  Latin America Allergy Immunotherapy Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Allergy Immunotherapy Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Allergy Immunotherapy Market Value, By Country, 2018 – 2028
TABLE  MEA Allergy Immunotherapy Market Value, By Segment1, 2018 – 2028
TABLE  MEA Allergy Immunotherapy Market Value, By Segment2, 2018 – 2028
TABLE  MEA Allergy Immunotherapy Market Value, By Country, 2018 – 2028
TABLE  Merck KGaA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  DBV Technologies: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ALK: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Allergy Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  HAL Allergy B.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aimmune Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Circassia: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Anergis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biomay AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Stallergenes Greer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Allergy Immunotherapy Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Allergy Immunotherapy Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Allergy Immunotherapy Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Allergy Immunotherapy Market, By Geography, 2019 (US$ Mn)
FIG.  Global Allergy Immunotherapy Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Allergy Immunotherapy Providers, 2016
FIG.  Global Allergy Immunotherapy Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global SCIT Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Allergy Immunotherapy Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies & Drug Stores Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Allergy Immunotherapy Market Value, 2018 – 2028, (US$ Mn)